EICHORCondition: Idiopathic Pulmonary Fibrosis · Sponsor: Mediar Therapeutics
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
This description comes directly from the study's public registry record.
Jeffrey Bornstein, MD · (617) 936-0960 · Jeffrey@mediartx.com
Katherine Palu · (617) 936-0960
Always discuss trial participation with your own doctor first.
| WISPer Site in Birmingham, AL | Birmingham, Alabama, United States | Recruiting |
| WISPer site in Phoenix, AZ | Phoenix, Arizona, United States | Recruiting |
| WISPer Site in Los Angeles, CA | Los Angeles, California, United States | Recruiting |
| WISPer site in Newport Beach, CA | Newport Beach, California, United States | Recruiting |
| WISPer Site in Palm Springs, CA | Palm Springs, California, United States | Recruiting |
| WISPer Site in Denver, CO | Denver, Colorado, United States | Recruiting |
| WISPer site in Loxahatchee, FL | Loxahatchee Groves, Florida, United States | Recruiting |
| WISPer Site in Atlanta, GA | Atlanta, Georgia, United States | Recruiting |
| WISPer site in Champaign, IL | Champaign, Illinois, United States | Recruiting |
| WISPer site in Kansas City, KS | Kansas City, Kansas, United States | Recruiting |
| WISPer Site in Louisville, KY | Louisville, Kentucky, United States | Recruiting |
| WISPer site in Shreveport, LA | Shreveport, Louisiana, United States | Recruiting |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06967805